NCT00256620
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +6 more
- Locations
-
- New York Presbyterian Hospital-Weill Medical Center New York, United States
Clinical trial condition
Arteriosclerosis
Explore clinical trials studying Arteriosclerosis. Study availability and eligibility vary by location and protocol.
5,359 public trials
756 recruiting studies
Arteriosclerosis trial results
NCT00648453
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +4 more
- Locations
-
- Sanofi-Aventis Budapest, Hungary
NCT00001904
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +10 more
- Locations
-
- National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States
NCT00001633
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
NCT00004549
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
Completed
Comparison of Magnetic Resonance Angiography and Standard Angiography in Diagnosing Atherosclerosis
NCT00001946
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +2 more
- Locations
-
- Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States
NCT00039663
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Blood-Borne Infections, +31 more
- Locations
-
- National Institutes of Health Clinical Center (CC) Bethesda, Maryland, United States
NCT00001889
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
NCT00045812
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +11 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
Completed
Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents
NCT00627900
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
- Locations
-
- Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie Berlin, Germany